Clinical Trial Update: Post-marketing Surveillance of Ventilat® Metered Dose Inhaler in Chronic Obstructive Bronchitis

View source ↗

Summary

A completed post-marketing surveillance study evaluating the Ventilat inhaler in chronic obstructive pulmonary disease reports safety data collected from real-w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Ventilat

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED